Leadership research · 4,000-source milestone

Actionable companion · Governance and equitable decisions

From leadership research to district action: Technological Doping in Sport: Performance Enhancement, Health, Ethics, and Regulatory Governance: A Narrative Synthesis

AI-assisted editorial implementation guide. Proposed district actions are separate from the original authors’ findings and recommendations. Independent peer review of this guide is not asserted.

Evidence and transfer

Education-related source: verify which participants, institutions and outcomes were actually studied before district adoption. Source publication type: review-article. License and identity checks do not establish study quality or causality.

Original authors’ abstract, reproduced under the source license:

Abstract Background: Technological innovation increasingly shapes modern sport, influencing performance, athlete safety, and regulatory governance. While new technologies enhance training and monitoring, they also raise concerns regarding fairness, health protection, and ethical legitimacy, commonly described as technological doping. The fragmented nature of the literature in this field requires integrative synthesis. Methods: A structured narrative synthesis was conducted using systematic searches and predefined eligibility criteria to identify studies addressing performance technologies, digital monitoring and detection systems, healthcare compliance, and governance and ethical frameworks. Twenty-four studies spanning empirical, policy, and conceptual domains were included. Results: Mechanical technologies, particularly advanced carbon-plate footwear, were associated with approximately 1–3% faster marathon performances and measurable alterations in lower-limb kinematics and kinetics under fatigue, while running-specific prostheses demonstrated performance-relevant differences in stiffness and energy return properties. Wearable monitoring systems supported training optimization but raised concerns related to surveillance and athlete autonomy. Artificial intelligence-based medication screening tools demonstrated high operational performance, with reported recognition accuracy ranging from approximately 92% to 98%, sensitivity approaching 1.00, and strong specificity for identifying prohibited substances from prescription images. Healthcare studies identified persistent knowledge gaps, medication risks, and the importance of pharmacists and education programs. Governance analyses revealed disparities in laboratory capacity and regulatory ambiguity when addressing emerging technologies, while ethical scholarship questioned the boundaries of legitimate enhancement. Conclusions: Technological doping reflects an interconnected performance–health–governance challenge rather than an isolated equipment issue. The synthesis demonstrates that technological doping is driven by measurable performance gains, digitally mediated compliance systems, and uneven regulatory capacity, indicating that future governance must shift from reactive equipment bans toward integrated, evidence-based oversight of biomechanical, digital, and healthcare technologies. Keywords: technological doping, sport technology, performance enhancement, anti-doping systems, wearable technologies, sports ethics, regulatory governance

Study methods

This narrative synthesis was conducted using a structured and transparent literature search strategy to ensure comprehensive identification of relevant evidence addressing technological doping in sport across performance enhancement, biomechanical mechanisms, healthcare implications, regulatory governance, and ethical considerations, including applied artificial intelligence-based technologies supporting athlete safety and anti-doping compliance [2]. Although the review adopted a narrative synthesis approach rather than a quantitative meta-analysis, methodological rigor was maintained through systematic searching, predefined eligibility criteria, independent screening, and structured data extraction, consistent with best-practice recommendations for high-quality narrative evidence synthesis and transparent reporting standards [27,28].

Limitations

Several limitations of the present narrative synthesis should be acknowledged. First, the included studies demonstrated substantial methodological heterogeneity, limiting direct comparability across performance, biomedical, and policy domains. Second, the absence of a formal risk-of-bias assessment restricts the ability to evaluate the internal validity of individual empirical findings. Third, reliance on English-language publications may have excluded relevant regulatory and technological evidence from non-English jurisdictions. Fourth, longitudinal health consequences of technologically enhanced performance remain insufficiently studied, limiting conclusions regarding long-term athlete welfare. Finally, regulatory capacity and ethical governance structures evolve rapidly, meaning that some policy interpretations may become outdated as technology and institutional frameworks continue to develop.

A 90-day district inquiry

  1. Days 1–15 · Appraise. Read the source methods, recruitment, comparator, outcomes and limitations. Record how the study setting differs from your district and which claim the design can support.
  2. Days 16–30 · Design. Select one recurring district decision. Publish the decision owner, evidence requirements, consultation process and appeal route; test the process on a bounded low-risk decision. Agree participation, privacy protections, baseline and stopping rules before starting.
  3. Days 31–60 · Observe. Collect the pre-agreed measures, keep a log of implementation changes and invite confidential voluntary feedback. Preserve existing support for staff and learners.
  4. Days 61–90 · Decide. Track decision time, unresolved objections, documented reasons, appeals and access differences. Review whether the process changes who can participate and who carries the burden. Make a dated decision to stop, revise or extend the inquiry.

Board decision brief

Present the local problem, source setting, evidence limits, intervention, responsible owner, total cost, measured changes and uncertainty. Separate staff perceptions, implementation measures and student learning outcomes.

Attribution and reuse

Dan Iulian Alexe; Prashant Kumar Choudhary; Suchishrava Choudhary; Sohom Saha; Bindiya Rawat; Dragoș Ioan Tohănean; Ecaterina Lungu; Cristina Ioana Alexe. Technological Doping in Sport: Performance Enhancement, Health, Ethics, and Regulatory Governance: A Narrative Synthesis. Bioengineering (2026-02-24). https://doi.org/10.3390/bioengineering13030257

Prepared 2026-11-07. Source authorship and DOI are preserved. The abstract and source passages are attributed extracts; this editorial guide is offered under the same CC BY 4.0 license.